Page last updated: 2024-11-05

ici 204,219 and Cystic Fibrosis of Pancreas

ici 204,219 has been researched along with Cystic Fibrosis of Pancreas in 2 studies

zafirlukast: a leukotriene D4 receptor antagonist

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Conway, SP1
Etherington, C1
Peckham, DG1
Whitehead, A1
Santais, MC1
Callens, E1
Djebbar, R1
Ruff, F1

Reviews

1 review available for ici 204,219 and Cystic Fibrosis of Pancreas

ArticleYear
[Potential importance of antileukotrienes in the treatment of asthma and other inflammatory diseases: apropos of a new pharmacological class].
    La Revue de medecine interne, 1998, Volume: 19, Issue:2

    Topics: Acetophenones; Adult; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthr

1998

Trials

1 trial available for ici 204,219 and Cystic Fibrosis of Pancreas

ArticleYear
A pilot study of zafirlukast as an anti-inflammatory agent in the treatment of adults with cystic fibrosis.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2003, Volume: 2, Issue:1

    Topics: Adult; Anti-Inflammatory Agents; Cystic Fibrosis; Female; Humans; Indoles; Leukotriene Antagonists;

2003